A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice

Alberto M. Davalli, Y. Ogawa, C. Ricordi, D. W. Scharp, S. Bonner-Weir, G. C. Weir

Research output: Contribution to journalArticle

Abstract

Streptozocin-induced diabetic nude mice (blood glucose 493±14 mg/dl) received aliquots of 2000 human islet equivalents (IE) under the kidney capsule and were then followed for up to 30 days with measurement of blood glucosc concentrations and body weight. Characterization of islet aliquots before the implantation included the assessment of the endocrine beta cell and nonbeta cell mass, estimated by point counting morphometry of immunostained sections. Islet transplantation was followed by a rapid decrease in blood glucose levels and by a progressive increase in body weight; 15 days after transplantation mean glycemic levels were 102±11 mg/dl and further decreased to 70±3 mg/dl at 30 days. Despite the progressive improvement in the glucose levels, the beta cell mass of the islet grafts significantly decreased over time from 2.63±0.2 mg, at the time of transplantation, to 1.16±0.1 and 0.86±0.1 mg 15 and 30 days, respectively, after transplantation. In contrast, the endocrine nonbeta cell mass remained stable from before the implantation to 30 days after. Therefore, the endocrine nonbeta cell/beta cell ratio increased from 14% at the time of transplantation, to 35% and 37%, 15 and 30 days, respectively, after transplantation. The rate of replication of the transplanted beta cells was similar in the grafts harvested at 15 and 30 days, with the percentage of beta cells positive for bromo-2’de-oxyuridine (BrdU) incorporation being in the range of ∼ 0.1% 6 hr after the BrdU injection. These data demonstrate that an important decrease in beta cell mass takes place immediately after islet transplantation—the most dramatic decrease occurring in the first 15 days and persisting even after revascularization has occurred. However, endocrine nonbeta cell mass remained stable indicating that engrafted nonbeta cells are less likely to die than beta cells. The finding that the nonbeta/beta cell ratio of a human islet graft can increase over time, raises questions about whether such a change in islet structure could have an influence upon function.

Original languageEnglish
Pages (from-to)817-820
Number of pages4
JournalTransplantation
Volume59
Issue number6
Publication statusPublished - Mar 27 1995

Fingerprint

Nude Mice
Endocrine Cells
Transplantation
Bromodeoxyuridine
Transplants
Blood Glucose
Body Weight
Islets of Langerhans Transplantation
Streptozocin
Islets of Langerhans
Capsules
Kidney
Glucose
Injections

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Davalli, A. M., Ogawa, Y., Ricordi, C., Scharp, D. W., Bonner-Weir, S., & Weir, G. C. (1995). A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation, 59(6), 817-820.

A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. / Davalli, Alberto M.; Ogawa, Y.; Ricordi, C.; Scharp, D. W.; Bonner-Weir, S.; Weir, G. C.

In: Transplantation, Vol. 59, No. 6, 27.03.1995, p. 817-820.

Research output: Contribution to journalArticle

Davalli, AM, Ogawa, Y, Ricordi, C, Scharp, DW, Bonner-Weir, S & Weir, GC 1995, 'A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice', Transplantation, vol. 59, no. 6, pp. 817-820.
Davalli AM, Ogawa Y, Ricordi C, Scharp DW, Bonner-Weir S, Weir GC. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation. 1995 Mar 27;59(6):817-820.
Davalli, Alberto M. ; Ogawa, Y. ; Ricordi, C. ; Scharp, D. W. ; Bonner-Weir, S. ; Weir, G. C. / A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. In: Transplantation. 1995 ; Vol. 59, No. 6. pp. 817-820.
@article{ad43bc7d6db34b129998f39b3ed03629,
title = "A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice",
abstract = "Streptozocin-induced diabetic nude mice (blood glucose 493±14 mg/dl) received aliquots of 2000 human islet equivalents (IE) under the kidney capsule and were then followed for up to 30 days with measurement of blood glucosc concentrations and body weight. Characterization of islet aliquots before the implantation included the assessment of the endocrine beta cell and nonbeta cell mass, estimated by point counting morphometry of immunostained sections. Islet transplantation was followed by a rapid decrease in blood glucose levels and by a progressive increase in body weight; 15 days after transplantation mean glycemic levels were 102±11 mg/dl and further decreased to 70±3 mg/dl at 30 days. Despite the progressive improvement in the glucose levels, the beta cell mass of the islet grafts significantly decreased over time from 2.63±0.2 mg, at the time of transplantation, to 1.16±0.1 and 0.86±0.1 mg 15 and 30 days, respectively, after transplantation. In contrast, the endocrine nonbeta cell mass remained stable from before the implantation to 30 days after. Therefore, the endocrine nonbeta cell/beta cell ratio increased from 14{\%} at the time of transplantation, to 35{\%} and 37{\%}, 15 and 30 days, respectively, after transplantation. The rate of replication of the transplanted beta cells was similar in the grafts harvested at 15 and 30 days, with the percentage of beta cells positive for bromo-2’de-oxyuridine (BrdU) incorporation being in the range of ∼ 0.1{\%} 6 hr after the BrdU injection. These data demonstrate that an important decrease in beta cell mass takes place immediately after islet transplantation—the most dramatic decrease occurring in the first 15 days and persisting even after revascularization has occurred. However, endocrine nonbeta cell mass remained stable indicating that engrafted nonbeta cells are less likely to die than beta cells. The finding that the nonbeta/beta cell ratio of a human islet graft can increase over time, raises questions about whether such a change in islet structure could have an influence upon function.",
author = "Davalli, {Alberto M.} and Y. Ogawa and C. Ricordi and Scharp, {D. W.} and S. Bonner-Weir and Weir, {G. C.}",
year = "1995",
month = "3",
day = "27",
language = "English",
volume = "59",
pages = "817--820",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice

AU - Davalli, Alberto M.

AU - Ogawa, Y.

AU - Ricordi, C.

AU - Scharp, D. W.

AU - Bonner-Weir, S.

AU - Weir, G. C.

PY - 1995/3/27

Y1 - 1995/3/27

N2 - Streptozocin-induced diabetic nude mice (blood glucose 493±14 mg/dl) received aliquots of 2000 human islet equivalents (IE) under the kidney capsule and were then followed for up to 30 days with measurement of blood glucosc concentrations and body weight. Characterization of islet aliquots before the implantation included the assessment of the endocrine beta cell and nonbeta cell mass, estimated by point counting morphometry of immunostained sections. Islet transplantation was followed by a rapid decrease in blood glucose levels and by a progressive increase in body weight; 15 days after transplantation mean glycemic levels were 102±11 mg/dl and further decreased to 70±3 mg/dl at 30 days. Despite the progressive improvement in the glucose levels, the beta cell mass of the islet grafts significantly decreased over time from 2.63±0.2 mg, at the time of transplantation, to 1.16±0.1 and 0.86±0.1 mg 15 and 30 days, respectively, after transplantation. In contrast, the endocrine nonbeta cell mass remained stable from before the implantation to 30 days after. Therefore, the endocrine nonbeta cell/beta cell ratio increased from 14% at the time of transplantation, to 35% and 37%, 15 and 30 days, respectively, after transplantation. The rate of replication of the transplanted beta cells was similar in the grafts harvested at 15 and 30 days, with the percentage of beta cells positive for bromo-2’de-oxyuridine (BrdU) incorporation being in the range of ∼ 0.1% 6 hr after the BrdU injection. These data demonstrate that an important decrease in beta cell mass takes place immediately after islet transplantation—the most dramatic decrease occurring in the first 15 days and persisting even after revascularization has occurred. However, endocrine nonbeta cell mass remained stable indicating that engrafted nonbeta cells are less likely to die than beta cells. The finding that the nonbeta/beta cell ratio of a human islet graft can increase over time, raises questions about whether such a change in islet structure could have an influence upon function.

AB - Streptozocin-induced diabetic nude mice (blood glucose 493±14 mg/dl) received aliquots of 2000 human islet equivalents (IE) under the kidney capsule and were then followed for up to 30 days with measurement of blood glucosc concentrations and body weight. Characterization of islet aliquots before the implantation included the assessment of the endocrine beta cell and nonbeta cell mass, estimated by point counting morphometry of immunostained sections. Islet transplantation was followed by a rapid decrease in blood glucose levels and by a progressive increase in body weight; 15 days after transplantation mean glycemic levels were 102±11 mg/dl and further decreased to 70±3 mg/dl at 30 days. Despite the progressive improvement in the glucose levels, the beta cell mass of the islet grafts significantly decreased over time from 2.63±0.2 mg, at the time of transplantation, to 1.16±0.1 and 0.86±0.1 mg 15 and 30 days, respectively, after transplantation. In contrast, the endocrine nonbeta cell mass remained stable from before the implantation to 30 days after. Therefore, the endocrine nonbeta cell/beta cell ratio increased from 14% at the time of transplantation, to 35% and 37%, 15 and 30 days, respectively, after transplantation. The rate of replication of the transplanted beta cells was similar in the grafts harvested at 15 and 30 days, with the percentage of beta cells positive for bromo-2’de-oxyuridine (BrdU) incorporation being in the range of ∼ 0.1% 6 hr after the BrdU injection. These data demonstrate that an important decrease in beta cell mass takes place immediately after islet transplantation—the most dramatic decrease occurring in the first 15 days and persisting even after revascularization has occurred. However, endocrine nonbeta cell mass remained stable indicating that engrafted nonbeta cells are less likely to die than beta cells. The finding that the nonbeta/beta cell ratio of a human islet graft can increase over time, raises questions about whether such a change in islet structure could have an influence upon function.

UR - http://www.scopus.com/inward/record.url?scp=0028963533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028963533&partnerID=8YFLogxK

M3 - Article

C2 - 7701574

AN - SCOPUS:0028963533

VL - 59

SP - 817

EP - 820

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -